Literature DB >> 10856942

Pathogenetic role of autoantibodies in neurological diseases.

J J Archelos1, H P Hartung.   

Abstract

Autoreactive B cells and antibodies can be detected in a variety of neurological diseases. Their causative role has been established in some disorders and they are obviously involved in the pathogenesis of others. Some mechanisms engendering B-cell autoimmunity in animal models have been shown to operate in humans. Factors that determine B-cell immune-response patterns and the effector pathways have been identified. B-cell responses to CNS-restricted autoantigens are governed by distinctive immune reactions. Evidence has accumulated that the CNS is a permissive and, under inflammatory conditions, even a B-cell-supporting micro-environment. Data from human and animal experiments have enhanced our understanding of B-cell physiology in health and neurological disease, which has relevant diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856942     DOI: 10.1016/s0166-2236(00)01575-7

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  27 in total

Review 1.  Retinopathies associated with antiretinal antibodies.

Authors:  J J Hooks; M O Tso; B Detrick
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy?

Authors:  Andrew S P Lim; Thomas E Scammell
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

Review 3.  B-cells and humoral immunity in multiple sclerosis. Implications for therapy.

Authors:  Sangjin Oh; Cornelia Cudrici; Takahiro Ito; Horea Rus
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Autoantibodies to glutamate receptors and products of nitric oxide metabolism in serum in children in the acute phase of craniocerebral trauma.

Authors:  E G Sorokina; Zh B Semenova; N A Bazarnaya; S V Meshcheryakov; V P Reutov; A V Goryunova; V G Pinelis; O K Granstrem; L M Roshal
Journal:  Neurosci Behav Physiol       Date:  2009-05

Review 5.  Advances in the understanding of the mechanism of action of IVIg.

Authors:  Hans-Peter Hartung
Journal:  J Neurol       Date:  2008-07       Impact factor: 4.849

6.  Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.

Authors:  Dafna Lotan; Itai Benhar; Kathy Alvarez; Adita Mascaro-Blanco; Lior Brimberg; Dan Frenkel; Madeleine W Cunningham; Daphna Joel
Journal:  Brain Behav Immun       Date:  2014-02-20       Impact factor: 7.217

Review 7.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

8.  Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Carmine Tamborino; Silva Seraceni; Maria Rosaria Tola; Enrico Granieri; Carlo Contini
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

Review 9.  [Targeting B cells in multiple sclerosis. Current concepts and strategies].

Authors:  T Menge; H-C Büdingen; M C Dalakas; B C Kieseier; H-P Hartung
Journal:  Nervenarzt       Date:  2009-02       Impact factor: 1.214

Review 10.  Immunopathogenic mechanisms in tourette syndrome: A critical review.

Authors:  Davide Martino; Russell C Dale; Donald L Gilbert; Gavin Giovannoni; James F Leckman
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.